Citizens Financial Group Inc Incyte Corp Transaction History

Citizens Financial Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$85.07 - $109.69 $4,848 - $6,252	-57 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$63.18 - $85.97 $568 - $773	9 Added 18.75%	57 $4,000
Q2 2019 Aug 09, 2019	SELL	$73.52 - $88.7 $514 - $620	-7 Reduced 12.73%	48 $4,000
Q1 2019 May 09, 2019	BUY	$63.56 - $88.17 $3,495 - $4,849	55 New	55 $5,000

618

215M

366K

445K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $12.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Citizens Financial Group Inc with notifications on news.